Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 7 of about 5 companies and 2 funds for MARK HAHN�
Company Exchange Symbol Last price Quote change Market cap
Cempra Inc NASDAQ CEMP 45.34 +1.81 (4.16%) 1.90B
Cempra Inc. is a clinical-stage pharmaceutical company focused on developing differentiated antibiotics for the acute care and community settings to meet ...
Executive:
Mark W. Hahn
GlycoMimetics Inc NASDAQ GLYC 7.49 +0.11 (1.49%) 140.35M
GlycoMimetics, Inc. (GlycoMimetics) is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs to ...
Executive:
Mark A. Goldberg MD
ALLY BANK Private
Ally Bank is on your side when it comes to banking. Formerly known as GMAC Bank, Ally Bank (which is a subsidiary of government-backed Ally Financial) ...
Executive:
Mark Bole
Canamex Resources Corp CVE CSQ 0.0400 0.0000 (0.00%) 5.17M
Canamex Resources Corp. is a Canada-based engaged in the process of acquiring mineral resource properties. The company is focused on its flagship gold ...
Executive:
Mark A. Billings
Cempra Holdings, LLC Private
Cempra Holdings isn't afraid of a little staph, or pneumonia for that matter. The company is in the clinical stages of developing antibiotics that treat ...
Executive:
Mark W. Hahn
Mutual Fund Symbol Nav Nav change
Principal Dynamic High Yield Explorer Fund Institutional Class Shares PDYIX 9.58 +0.01 (0.10%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.
Principal Dynamic High Yield Explorer Fund Class A Shares PDYAX 9.57 +0.02 (0.21%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.